Autonomix Medical, Inc.

Stage 4 · Declining · week 98

As of Oct 22, 2026, Autonomix Medical is in Stage 4, the downtrend phase, now in week 98 (since Nov 11, 2024). It closed at $2.50, 89.6% below its 52-week high and below its 200-day average, which is falling.

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. More about the company

$2.50

-2.72% today

$4.9M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is AMIX early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2024-01-29 → 2026-10-22

S? 41w

S4 102w

2024-01-292026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 41w → S4 102w current

Total tracked: 142 weeks across 2 stage runs.

AMIX among Medical Devices118th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…118	AMIXAutonomix Medical, Inc.	Stage 4 · wk 98	7	−37.2%

vs 52W High

-89.6%

$2.50 lo$24.15 hi

89.6% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 98

1w13w26w

Week 98, extended decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-64.5%

200 DMA: $7.05 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.03x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-37.2%

-14.4%

-67.7%

YTD

-77.8%

-89.3%

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S4

Wk 98 · Vol 0.03x

2026-10-21S4

Wk 98 · Vol 0.01x

2026-10-20S4

Wk 98 · Vol 0.02x

2026-10-19S4

Wk 97 · Vol 0.03x

2026-10-16S4

Wk 97 · Vol 0.03x

2026-10-15S4

Wk 97 · Vol 0.02x

2026-10-14S4

Wk 97 · Vol 0.01x

2026-10-13S4

Wk 97 · Vol 0.01x

2026-10-12S4

Wk 96 · Vol 0.01x

2026-10-09S4

Wk 96 · Vol 0.01x

2026-10-08S4

Wk 96 · Vol 0.02x

2026-10-07S4

Wk 96 · Vol 0.01x

Moving averages & range

50 DMA

$4.32

200 DMA

$7.05

52W High

$24.15

52W Low

$2.50

5D Low

$2.50

Resistance levels (recent highs)

20d High

$4.02

60d High

$19.50

120d High

$19.50

250d High

$24.15

Next resistance

+60.8%

to 20d High

ROE

-316.0%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 0.4

Autonomix Medical: quick answers

What stage is Autonomix Medical in?

As of Oct 22, 2026, Autonomix Medical (AMIX) is in Stage 4, the downtrend phase. It entered Stage 4 on Nov 11, 2024 and is in week 98. What the four stages mean

Is Autonomix Medical in an uptrend?

No. Autonomix Medical is in a Stage 4 downtrend. It trades 64.5% below its 200-day average, which is falling.

How far is Autonomix Medical from its 52-week high?

Autonomix Medical closed at $2.50 on Oct 22, 2026, 89.6% below its 52-week high of $24.15. Its 52-week low is $2.50.

How has Autonomix Medical performed over the past year?

As of Oct 22, 2026, Autonomix Medical is down 89.3% over the past year and down 77.8% so far in 2026.

Which sector and industry is Autonomix Medical in?

Autonomix Medical is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.